title: Recruitment to Golgi membranes of ADP-ribosylation factor 1 is mediated by the cytoplasmic domain of p23.
abstract: Binding to Golgi membranes of ADP ribosylation factor 1 (ARF1) is the first event in the initiation of COPI coat assembly. Based on binding studies, a proteinaceous receptor has been proposed to be critical for this process. We now report that p23, a member of the p24 family of Golgi-resident transmembrane proteins, is involved in ARF1 binding to membranes. Using a cross-link approach based on a photolabile peptide corresponding to the cytoplasmic domain of p23, the GDP form of ARF1 (ARF1-GDP) is shown to interact with p23 whereas ARF1-GTP has no detectable affinity to p23. The p23 binding is shown to localize specifically to a 22 amino acid C-terminal fragment of ARF1. While a monomeric form of a non-photolabile p23 peptide does not significantly inhibit formation of the cross-link product, the corresponding dimeric form does compete efficiently for this interaction. Consistently, the dimeric p23 peptide strongly inhibits ARF1 binding to native Golgi membranes suggesting that an oligomeric form of p23 acts as a receptor for ARF1 before nucleotide exchange takes place.
authors.affiliation: Biochemie-Zentrum Heidelberg, Ruprecht-Karls-Universität, Im Neuenheimer Feld 328, D-69120 Heidelberg, Germany.
authors.forename: D U
authors.initials: DU
authors.lastname: Gommel
authors.forename: A R
authors.initials: AR
authors.lastname: Memon
authors.forename: A
authors.initials: A
authors.lastname: Heiss
authors.forename: F
authors.initials: F
authors.lastname: Lottspeich
authors.forename: J
authors.initials: J
authors.lastname: Pfannstiel
authors.forename: J
authors.initials: J
authors.lastname: Lechner
authors.forename: C
authors.initials: C
authors.lastname: Reinhard
authors.forename: J B
authors.initials: JB
authors.lastname: Helms
authors.forename: W
authors.initials: W
authors.lastname: Nickel
authors.forename: F T
authors.initials: FT
authors.lastname: Wieland
mesh_terms: D020823:ADP-Ribosylation Factor 1 / Q000737:chemistry* / Q000378:metabolism*; D000595:Amino Acid Sequence; D001665:Binding Sites; D003432:Cross-Linking Reagents / Q000494:pharmacology; D003593:Cytoplasm / Q000378:metabolism*; D019281:Dimerization; D004305:Dose-Response Relationship, Drug; D004791:Enzyme Inhibitors / Q000494:pharmacology; D006056:Golgi Apparatus / Q000378:metabolism*; D006153:Guanosine Diphosphate / Q000378:metabolism; D006801:Humans; D007425:Intracellular Membranes / Q000378:metabolism; D008027:Light; D008565:Membrane Proteins / Q000737:chemistry / Q000378:metabolism*; D008954:Models, Biological; D008969:Molecular Sequence Data; D010455:Peptides / Q000737:chemistry; D011485:Protein Binding; D017434:Protein Structure, Tertiary; D018160:Receptors, Cytoplasmic and Nuclear; D011994:Recombinant Proteins / Q000378:metabolism; D013861:Thiocyanates / Q000494:pharmacology
chemical_list: C108779:BHKp23 protein, mammalian; D003432:Cross-Linking Reagents; D004791:Enzyme Inhibitors; D008565:Membrane Proteins; D010455:Peptides; D018160:Receptors, Cytoplasmic and Nuclear; D011994:Recombinant Proteins; D013861:Thiocyanates; D006153:Guanosine Diphosphate; D020823:ADP-Ribosylation Factor 1; C008658:2-nitro-5-thiocyanobenzoic acid